Leukemoid Reaction: Difference between revisions

 
Line 3: Line 3:
* Cutoff is variable, 25-50k<ref>Sakka V, Tsiodras S, Giamarellos-Bourboulis EJ, Giamarellou H. An update on the etiology and diagnostic evaluation of a leukemoid reaction. Eur J Intern Med. 2006;17(6):394-398. doi:10.1016/j.ejim.2006.04.004.</ref>
* Cutoff is variable, 25-50k<ref>Sakka V, Tsiodras S, Giamarellos-Bourboulis EJ, Giamarellou H. An update on the etiology and diagnostic evaluation of a leukemoid reaction. Eur J Intern Med. 2006;17(6):394-398. doi:10.1016/j.ejim.2006.04.004.</ref>


==Literature Review==
===Literature Review===
=== Retrospective review of 135 patients with WBC >25k <ref>Reding MT, Hibbs JR, Morrison VA, Swaim WR, Filice GA. Diagnosis and outcome of 100 consecutive patients with extreme granulocytic leukocytosis. Am J Med. 1998;104(1):12-16.</ref> ===
==== Retrospective review of 135 patients with WBC >25k <ref>Reding MT, Hibbs JR, Morrison VA, Swaim WR, Filice GA. Diagnosis and outcome of 100 consecutive patients with extreme granulocytic leukocytosis. Am J Med. 1998;104(1):12-16.</ref> ====
* 48% infection
* 48% infection
* 15% malignancy
* 15% malignancy
Line 10: Line 10:
* 12% glucocorticoid or granulocyte colony stimulating therapy
* 12% glucocorticoid or granulocyte colony stimulating therapy


=== Retrospective review of 173 patients with WBC >30k <ref>Potasman I, Grupper M. Leukemoid reaction: spectrum and prognosis of 173 adult patients. Clin Infect Dis. 2013;57(11):e177-e181. doi:10.1093/cid/cit562.</ref> ===
==== Retrospective review of 173 patients with WBC >30k <ref>Potasman I, Grupper M. Leukemoid reaction: spectrum and prognosis of 173 adult patients. Clin Infect Dis. 2013;57(11):e177-e181. doi:10.1093/cid/cit562.</ref> ====
* 48% infection (7% C. difficile)
* 48% infection (7% C. difficile)
* 28% tissue ischemia
* 28% tissue ischemia
Line 16: Line 16:
* 5% malignancy
* 5% malignancy


=== Observational study of 54 patients with WBC >25k <ref>Lawrence YR, Raveh D, Rudensky B, Munter G. Extreme leukocytosis in the emergency department. QJM. 2007;100(4):217-223. doi:10.1093/qjmed/hcm006.</ref> ===
==== Observational study of 54 patients with WBC >25k <ref>Lawrence YR, Raveh D, Rudensky B, Munter G. Extreme leukocytosis in the emergency department. QJM. 2007;100(4):217-223. doi:10.1093/qjmed/hcm006.</ref> ====
* Consecutive patients presenting to the emergency department
* Consecutive patients presenting to the emergency department
* Compared to age-matched controls with moderate leukocytosis (12-24k)
* Compared to age-matched controls with moderate leukocytosis (12-24k)

Latest revision as of 21:47, 11 January 2023

Background

  • Markedly elevated leukocyte (particularly neutrophil) count without hematologic malignancy
  • Cutoff is variable, 25-50k[1]

Literature Review

Retrospective review of 135 patients with WBC >25k [2]

  • 48% infection
  • 15% malignancy
  • 9% hemorrhage
  • 12% glucocorticoid or granulocyte colony stimulating therapy

Retrospective review of 173 patients with WBC >30k [3]

  • 48% infection (7% C. difficile)
  • 28% tissue ischemia
  • 7% obstetric process (vaginal or cesarean delivery)
  • 5% malignancy

Observational study of 54 patients with WBC >25k [4]

  • Consecutive patients presenting to the emergency department
  • Compared to age-matched controls with moderate leukocytosis (12-24k)
  • Patients with leukemoid reaction were more likely to have an infection, be hospitalized and die.

Clinical Features

  • Signs/symptoms of underlying pathology or asymptomatic

Differential Diagnosis

Differential Diagnosis of Leukemoid Reaction

Management

  • Treat underlying condition

Disposition

External Links

References

  1. Sakka V, Tsiodras S, Giamarellos-Bourboulis EJ, Giamarellou H. An update on the etiology and diagnostic evaluation of a leukemoid reaction. Eur J Intern Med. 2006;17(6):394-398. doi:10.1016/j.ejim.2006.04.004.
  2. Reding MT, Hibbs JR, Morrison VA, Swaim WR, Filice GA. Diagnosis and outcome of 100 consecutive patients with extreme granulocytic leukocytosis. Am J Med. 1998;104(1):12-16.
  3. Potasman I, Grupper M. Leukemoid reaction: spectrum and prognosis of 173 adult patients. Clin Infect Dis. 2013;57(11):e177-e181. doi:10.1093/cid/cit562.
  4. Lawrence YR, Raveh D, Rudensky B, Munter G. Extreme leukocytosis in the emergency department. QJM. 2007;100(4):217-223. doi:10.1093/qjmed/hcm006.